778
Views
20
CrossRef citations to date
0
Altmetric
Review

Influenza vaccination and prevention of antimicrobial resistance

&
Pages 881-888 | Received 02 Aug 2018, Accepted 14 Sep 2018, Published online: 12 Oct 2018

References

  • Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Med. 2006;119(Suppl 1):S3–S10.
  • Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13:1057–1098.
  • Meek RW, Vyas H, Piddock LJ. Nonmedical uses of antibiotics: time to restrict their use? PLoS Biol. 2015;13:e1002266.
  • Piddock LJ. The crisis of no new antibiotics–what is the way forward? Lancet Infect Dis. 2012;12:249–253.
  • Eliopoulos GM, Cosgrove SE, Carmeli Y. The impact of antibacterial resistance on health and economic outcomes. Clin Infect Dis. 2003;36:1433–1437.
  • Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016;22:416–422.
  • The Review on Antimicrobial Resistance, Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. 2014 December [cited 2018 Aug 01]. Available from: https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf
  • Nathan C, Cars O. Antibiotic resistance–problems, progress, and prospects. N Engl J Med. 2014;371:1761–1763.
  • Darvishian M, Bijlsma MJ, Hak E, et al. Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies. Lancet Infect Dis. 2014;14:1228–1239.
  • Principi N, Senatore L, Esposito S. Protection of young children from influenza through universal vaccination. Hum Vaccin Immunother. 2015;11:2350–2358.
  • Esposito S, Principi N. Different influenza vaccine formulations and adjuvants for childhood influenza vaccination. Vaccine. 2011;29:7535–7541.
  • Demicheli V, Jefferson T, Di Pietrantonj C, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2018;2: CD004876.
  • Demicheli V, Jefferson T, Ferroni E, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2018;2: CD001269.
  • Coelingh K, Olajide IR, MacDonald P, et al. Efficacy and effectiveness of live attenuated influenza vaccine in school-age children. Expert Rev Vaccines. 2015;14:1331–1346.
  • Alsan M, Morden NE, Gottlieb JD, et al. Antibiotic use in cold and flu season and prescribing quality: a retrospective cohort study. Med Care. 2015;53:1066–1071.
  • Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011. JAMA. 2016;315:1864–1873.
  • Weinstein L. The misuse and abuse of antimicrobial agents. Chic Med. 1962;65:9–16.
  • Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543.
  • Principi N, Esposito S. Antimicrobial stewardship in paediatrics. BMC Infect Dis. 2016;16:424.
  • Nagel JL, Kaye KS, LaPlante KL, et al. Antimicrobial stewardship for the infection control practitioner. Infect Dis Clin North Am. 2016;30:771–784.
  • Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225–231.
  • Misurski DA, Lipson DA, Changolkar AK. Inappropriate antibiotic prescribing in managed care subjects with influenza. Am J Manag Care. 2011;17:601–608.
  • Ghazi IM, Nicolau DP, Nailor MD, et al. Antibiotic utilization and opportunities for stewardship among hospitalized patients with influenza respiratory tract infection. Infect Control Hosp Epidemiol. 2016;37:583–589.
  • Durkin MJ, Jafarzadeh SR, Hsueh K, et al. Outpatient antibiotic prescription trends in the United States: a national cohort study. Infect Control Hosp Epidemiol. 2018;39:584–589.
  • Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009;302:758–766.
  • Klein EY, Monteforte B, Gupta A, et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2016;10:394–403.
  • Ruf BR, Knuf M. The burden of seasonal and pandemic influenza in infants and children. Eur J Pediatr. 2014;173:265–276.
  • Antonova EN, Rycroft CE, Ambrose CS, et al. Burden of paediatric influenza in Western Europe: a systematic review. BMC Public Health. 2012;12:968.
  • Chonmaitree T, Trujillo R, Jennings K, et al. Acute otitis media and other complications of viral respiratory infection. Pediatrics. 2016;137:pii: e20153555.
  • Coticchia JM, Chen M, Sachdeva L, et al. New paradigms in the pathogenesis of otitis media in children. Front Pediatr. 2013;1:52.
  • Mina MJ, Klugman KP, Rosch JW, et al. Live attenuated influenza virus increases pneumococcal translocation and persistence within the middle ear. J Infect Dis. 2015;212:195–201.
  • Verhoeven D, Nesselbush M, Pichichero ME. Lower nasopharyngeal epithelial cell repair and diminished innate inflammation responses contribute to the onset of acute otitis media in otitis-prone children. Med Microbiol Immunol. 2013;202:295–302.
  • Ubukata K, Morozumi M, Sakuma M, et al. Etiology of acute otitis media and characterization of pneumococcal isolates after introduction of 13-valent pneumococcal conjugate vaccine in Japanese children. Pediatr Infect Dis J. 2018;37:598–604.
  • Rosenfeld RM, Kay D. Natural history of untreated otitis media. Laryngoscope. 2003;113:1645–1657.
  • Ovnat Tamir S, Shemesh S, Oron Y, et al. Acute otitis media guidelines in selected developed and developing countries: uniformity and diversity. Arch Dis Child. 2017;102:450–457.
  • Deniz Y, van Uum RT, Mla DH, et al. Impact of acute otitis media clinical practice guidelines on antibiotic and analgesic prescriptions: a systematic review. Arch Dis Child. 2018;103: 597–602.
  • Marom T, Bobrow M, Eviatar E, et al. Adherence to acute otitis media diagnosis and treatment guidelines among Israeli otolaryngologists. Int J Pediatr Otorhinolaryngol. 2017;95:63–68.
  • Palma S, Rosafio C, Del Giovane C, et al. The impact of the Italian guidelines on antibiotic prescription practices for acute otitis media in a paediatric emergency setting. Ital J Pediatr. 2015;41:37.
  • Kronman MP, Zhou C, Mangione-Smith R. Bacterial prevalence and antimicrobial prescribing trends for acute respiratory tract infections. Pediatrics. 2014;134:e956–965.
  • Coco AS, Horst MA, Gambler AS. Trends in broad-spectrum antibiotic prescribing for children with acute otitis media in the United States, 1998–2004. BMC Pediatr. 2009;9:41.
  • Talbot TR, Poehling KA, Hartert TV, et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med. 2005;118:285–291.
  • de Roux A, Ewig S, García E, et al. Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J. 2006;27:795–800.
  • Dawood FS, Fiore A, Kamimoto L, et al. Influenza-associated pneumonia in children hospitalized with laboratory-confirmed influenza, 2003–2008. Pediatr Infect Dis J. 2010;29:585–590.
  • Blumental S, Huisman E, Cornet MC, et al. Pandemic A/H1N1v influenza 2009 in hospitalized children: a multicenter Belgian survey. BMC Infect Dis. 2011;11:313.
  • Lochindarat S, Bunnag T. Clinical presentations of pandemic 2009 influenza A (H1N1) virus infection in hospitalized Thai children. J Med Assoc Thai. 2011;94(Suppl 3):S107–S112.
  • Park SI, Kim MJ, Hwang HY, et al. Clinical characteristics of children with 2009 pandemic influenza A (H1N1) admitted in a single institution. Korean J Pediatr. 2010;53:886–891.
  • Sharon N, Talnir R, Lavid O, et al. Transient lymphopenia and neutropenia: pediatric influenza A/H1N1 infection in a primary hospital in Israel. Isr Med Assoc J. 2011;13:408–412.
  • Metersky ML, Masterton RG, Lode H, et al. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis. 2012;16:e321–e331.
  • Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis. 2004;190:1369–1373.
  • McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19:571–582.
  • Rynda-Apple A, Robinson KM, Alcorn JF. Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease. Infect Immun. 2015;83:3764–3770.
  • Shieh WJ, Blau DM, Denison AM, et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol. 2010;177:166–175.
  • Esposito S, Cohen R, Domingo JD, et al. Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J. 2012;31:e78–e85.
  • Bradley JS, Byington CL, Shah SS, et al. Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:617–630.
  • British Thoracic Society. BTS guidelines for the management of community acquired pneumonia in adults. Thorax. 2001;56(Suppl 4):IV1–64.
  • Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72.
  • Rossio R, Franchi C, Ardoino I, et al. Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia. Eur J Intern Med. 2015;26:330–337.
  • Lindhardt T, Klausen HH, Christiansen C, et al. Elderly patients with community-acquired pneumonia are not treated according to current guidelines. Dan Med J. 2013;60:A4572.
  • Robinson HL, Robinson PC, Whitby M. Poor compliance with community-acquired pneumonia antibiotic guidelines in a large Australian private hospital emergency department. Microb Drug Resist. 2014;20:561–567.
  • Castilla J, Godoy P, Domínguez A, et al. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis. 2013;57:167–175.
  • Shibata N, Kimura S, Hoshino T, et al. Effectiveness of influenza vaccination for children in Japan: four-year observational study using a large-scale claims database. Vaccine. 2018;36: 2809–2815.
  • Chiu SS, Kwan MYW, Feng S, et al. Influenza vaccine effectiveness against influenza A(H3N2) hospitalizations in children in Hong Kong in a prolonged season, 2016/2017. J Infect Dis. 2018;217:1365–1371.
  • Restivo V, Costantino C, Bono S, et al. Influenza vaccine effectiveness among high-risk groups: a systematic literature review and meta-analysis of case-control and cohort studies. Hum Vaccin Immunother. 2018;14:724–735.
  • Rondy M, El Omeiri N, Thompson MG, et al. Effectiveness of influenza vaccines in preventing severe influenza illness among adults: a systematic review and meta-analysis of test-negative design case-control studies. J Infect. 2017;75: 381–394.
  • Esposito S, Marchisio P, Cavagna R, et al. Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. Vaccine. 2003;21:3162–3168.
  • Esposito S, Cecinati V, Scicchitano B, et al. Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy. Vaccine. 2010;28:1558–1565.
  • Maltezou HC, Fotiou A, Antonakopoulos N, et al. Impact of postpartum influenza vaccination of mothers and household contacts in preventing febrile episodes, influenza-like illness, healthcare seeking, and administration of antibiotics in young infants during the 2012–2013 influenza season. Clin Infect Dis. 2013;57:1520–1526.
  • Kwong JC, Maaten S, Upshur RE, et al. The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis. 2009;49:750–756.
  • Hardelid P, Ghebremichael-Weldeselassie Y, Whitaker H, et al. Effectiveness of live attenuated influenza vaccine in preventing amoxicillin prescribing in preschool children: a self-controlled case series study. J Antimicrob Chemother. 2018;73: 779–786.
  • Principi N, Baggi E, Esposito S. Prevention of acute otitis media using currently available vaccines. Future Microbiol. 2012;7:457–465.
  • Norhayati MN, Ho JJ, Azman MY. Influenza vaccines for preventing acute otitis media in infants and children. Cochrane Database Syst Rev. 2017;10: CD010089.
  • Heikkinen T, Ruuskanen O, Waris M, et al. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child. 1991;145:445–448.
  • Clements DA, Langdon L, Bland C, et al. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med. 1995;149:1113–1117.
  • Marchisio P, Cavagna R, Maspes B, et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clin Infect Dis. 2002;35:168–174.
  • Block SL, Heikkinen T, Toback SL, et al. The efficacy of live attenuated influenza vaccine against influenza-associated acute otitis media in children. Pediatr Infect Dis J. 2011;30:203–207.
  • Wu PW, Huang CC, Chao WC, et al. Impact of influenza vaccine on childhood otitis media in Taiwan: a population-based study. PLoS One. 2018;13:e0190507.
  • Talbot HK, Zhu Y, Chen Q, et al. Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011–2012 influenza season. Clin Infect Dis. 2013;56:1774–1777.
  • Puig-Barbera J, Diez-Domingo J, Arnedo-Pena A, et al. Effectiveness of the 2010–2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study. Vaccine. 2012;30:5714–5720.
  • Talbot HK, Griffin MR, Chen Q, et al. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis. 2011;203:500–508.
  • Kwong JC, Campitelli MA, Gubbay JB, et al. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010–2011 season. Clin Infect Dis. 2013;57:820–827.
  • Staat MA, Griffin MR, Donauer S, et al. Vaccine effectiveness for laboratory-confirmed influenza in children 6–59 months of age, 2005–2007. Vaccine. 2011;29:9005–9011.
  • Menniti-Ippolito F, Da Cas R, Traversa G, et al. Vaccine effectiveness against severe laboratory confirmed influenza in children: results of two consecutive seasons in Italy. Vaccine. 2014;32:4466–4470.
  • Jain VK, Rivera L, Zaman K, et al. Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med. 2013;369:2481–2491.
  • Jackson ML, Nelson JC, Weiss NS, et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet. 2008;372:398–405.
  • Ferdinands JM, Gargiullo P, Haber M, et al. Inactivated influenza vaccines for prevention of community-acquired pneumonia: the limits of using nonspecific outcomes in vaccine effectiveness studies. Epidemiology. 2013;24:530–537.
  • Tessmer A, Welte T, Schmidt-Ott R, et al. Influenza vaccination is associated with reduced severity of community-acquired pneumonia. Eur Respir J. 2011;38:147–153.
  • Grijalva CG, Zhu Y, Williams DJ, et al. Association between hospitalization with community-acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination. JAMA. 2015;314:1488–1497.
  • de Vries RD, Altenburg AF, Rimmelzwaan GF. Universal influenza vaccines, science fiction or soon reality? Expert Rev Vaccines. 2015;14:1299–1301.
  • Rogers Van Katwyk S, Jm G, Mendelson M, et al. Government policy interventions to reduce human antimicrobial use: protocol for a systematic review and meta-analysis. Syst Rev. 2017;6:256.
  • Dobson EL, Klepser ME, Pogue JM, et al. Outpatient antibiotic stewardship: interventions and opportunities. J Am Pharm Assoc. 2017;57:464–473.
  • Clift C, Salisbury DM. Enhancing the role of vaccines in combatting antimicrobial resistance. Vaccine. 2017;35(48Pt B):6591–6593.
  • National Vaccine Advisory Committee. A call for greater consideration for the role of vaccines in national strategies to combat antibiotic-resistant bacteria: recommendations from the National Vaccine Advisory Committee. Public Health Reports. 2016;131:11–16.
  • Wroe PC, Lee GM, Finkelstein JA, et al. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J. 2012;31:249–254.
  • Principi N, Camilloni B, Esposito S. Influenza immunization policies: which could be the main reasons for differences among countries? Hum Vaccin Immunother. 2018;14:684–692.
  • Green DA, St George K. Rapid antigen tests for influenza: rationale and significance of the FDA reclassification. J Clin Microbiol 2018. Epub Jun 13.
  • Esposito S, Marchisio P, Morelli P, et al. Effect of a rapid influenza diagnosis. Arch Dis Child. 2003;88:525–526.
  • Hedrick JA, Barzilai A, Behre U, et al. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Pediatr Infect Dis J. 2000;19:410–417.
  • Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001;20:127–133.
  • Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US oral neuraminidase study group. JAMA. 2000;283:1016–1024.
  • Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med. 2003;163:1667–1672.
  • Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase inhibitor flu treatment investigator group. Lancet. 2000;355:1845–1850.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.